Repligen(RGEN)

Search documents
Repligen(RGEN) - 2022 Q2 - Earnings Call Transcript
2022-08-02 16:48
Repligen Corporation (NASDAQ:RGEN) Q2 2022 Earnings Conference Call August 2, 2022 8:30 AM ET Company Participants Sondra Newman – Head-Investor Relations Tony Hunt – President and Chief Executive Officer Jon Snodgres – Chief Financial Officer Conference Call Participants Dan Arias – Stifel Julia Qin – J.P. Morgan Jacob Johnson – Stephens Lisa Garcia – UBS Matt Larew – William Blair Paul Knight – KeyBanc Matt Hewitt – Craig-Hallum Capital Group Puneet Souda – SVB Securities Operator Good morning and welcome ...
Repligen(RGEN) - 2022 Q1 - Quarterly Report
2022-04-27 20:15
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-14656 REPLIGEN CORPORATION (Exact Name of Registrant as Specified in its Charter) Delaware 04-2729386 (State or Other Jurisdiction of Incorpora ...
Repligen(RGEN) - 2022 Q1 - Earnings Call Transcript
2022-04-27 18:58
Repligen Corporation (NASDAQ:RGEN) Q1 2022 Results Earnings Conference Call April 27, 2022 8:30 AM ET Company Participants Sondra Newman - Vice President and Global Head of Investor Relations Tony Hunt - President and Chief Executive Officer Jon Snodgres - Chief Financial Officer Conference Call Participants Jacob Johnson - Stephens Inc. Dan Arias - Stifel Financial Puneet Souda - SVB Leerink Julia Qin - J.P. Morgan Paul Knight - KeyBanc Capital Markets Justin Lin - William Blair & Company Matthew Hewitt - ...
Repligen(RGEN) - 2021 Q4 - Annual Report
2022-02-17 21:32
Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION | OR | | --- | | ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | | For the transition period from to | | Commission File Number 000-14656 | | REPLIGEN CORPORATION | | (Exact name of registrant as specified in its charter) | | Delaware 04-2729386 | | (State or other jurisdiction of (I.R.S. Employer | | incorporation or organization) Identification No.) | | 41 Seyon Street, Bldg. 1, S ...
Repligen(RGEN) - 2021 Q4 - Earnings Call Transcript
2022-02-17 16:53
Repligen Corporation (NASDAQ:RGEN) Q4 2021 Earnings Conference Call February 17, 2021 8:30 AM ET Company Participants Tony Hunt - President, Chief Executive Officer Jon Snodgres - Chief Financial Officer Sondra Newman - Head of Investor Relations Conference Call Participants Dan Arias - Stifel Jacob Johnson - Stephens Julia Qin - JP Morgan Paul Knight - Keybanc Matt Hewitt - Craig Hallum Capital Brandon Couillard - Jefferies Ram Selvaraju - HC Wainwright Operator Good day ladies and gentlemen and welcome t ...
Repligen(RGEN) - 2021 Q3 - Quarterly Report
2021-10-28 20:51
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-14656 REPLIGEN CORPORATION (Exact Name of Registrant as Specified in its Charter) Delaware 04-2729386 (State or Other Jurisdiction of Incor ...
Repligen(RGEN) - 2021 Q3 - Earnings Call Transcript
2021-10-28 19:43
Repligen Corporation (NASDAQ:RGEN) Q3 2021 Earnings Conference Call October 28, 2021 8:30 AM ET Company Participants Sondra Newman - Head of Investor Relations Anthony Hunt - President and Chief Executive Officer Jon Snodgres - Chief Financial Officer Conference Call Participants Daniel Arias - Stifel, Nicolaus & Company, Inc. Julia Qin - JPMorgan Chase & Co. Puneet Souda - SVB Leerink LLC Jacob Johnson - Stephens Inc. Paul Knight - KeyBanc Capital Markets Inc. Christine Rains - William Blair & Company Matt ...
Repligen(RGEN) - 2021 Q2 - Quarterly Report
2021-07-27 20:47
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-14656 REPLIGEN CORPORATION (Exact Name of Registrant as Specified in its Charter) Delaware 04-2729386 (State or Other Juri ...
Repligen(RGEN) - 2021 Q1 - Earnings Call Transcript
2021-07-27 15:13
Repligen Corp, Inc. (NASDAQ:RGEN) Q2 2021 Earnings Conference Call July 27, 2021 8:30 AM ET Company Participants Sondra Newman - Global Head, IR Anthony Hunt - CEO, President & Director Jon Snodgres - CFO Conference Call Participants Daniel Arias - Stifel, Nicolaus & Company Puneet Souda - SVB Leerink John Kreger - William Blair & Company Julia Qin - JPMorgan Chase & Co. Jacob Johnson - Stephens Inc. Matthew Hewitt - Craig-Hallum Paul Knight - KeyBanc Capital Markets Raghuram Selvaraju - H.C. Wainwright & C ...
Repligen(RGEN) - 2021 Q1 - Quarterly Report
2021-05-04 20:21
Table of Contents FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-14656 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (I.R.S. Employer Identification No.) (781) 250-0111 Registrant's Telephone Number, Including Area Code Securities r ...